DIABAID – Instituto de asistencia integral en diabetes y patologías crónicas, CABA, Buenos Aires

DIABAID – Instituto de asistencia integral en diabetes y patologías crónicas, CABA, Buenos Aires
Paraguay 1570, CABA, Buenos Aires
Select an option
Our team
Medical staff
Elena Fiorenza
Cintia Novas
Norma Haydee Deri
Rosana Guerreros
Karina Vera
Anahi Martinez
Maximiliano Romero
Cintia Novas
Luciana Bella Quero
Open studies
Skin cancer
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma - Regeneron PharmaceuticalsSee more
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery - Regeneron PharmaceuticalsSee more
Lung cancer
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer. - eVOLVE-Lung02 - AstraZenecaSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy